已发表论文

MiR-129-5p 通过下调 LncRNA Lnc712 抑制人骨肉瘤细胞增殖

 

Authors Yu Y, Zuo W, Cai W, Xu Y, Liu W, Zhao Z

Received 14 October 2020

Accepted for publication 14 February 2021

Published 10 March 2021 Volume 2021:13 Pages 2259—2264

DOI https://doi.org/10.2147/CMAR.S284078

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Eileen O'Reilly

Introduction: Lnc712 has been characterized as an oncogenic lncRNA in breast cancer. This study aimed to investigate the role of Lnc712 in osteosarcoma (OS).
Methods: OS and paired non-tumor tissues were collected from 58 OS patients. Expression of Lnc712 and miR-129-5p in paired tissue samples was determined by RT-qPCR. Lnc712 and miR-129-5p expression was achieved in OS cells to study the interaction between them. Cell proliferation was analyzed by CCK-8 assay.
Results: Lnc712 was upregulated in OS and was inversely correlated with miR-129-5p. In OS cells, Lnc712 overexpression failed to significantly affect miR-129-5p, while miR-129-5p overexpression led to downregulated Lnc712. Cell proliferation showed that Lnc712 overexpression resulted in increased cell proliferation rate. MiR-129-5p overexpression played an opposite role and reversed the effect of Lnc712 overexpression.
Discussion: MiR-129-5p may suppress cell proliferation of OS by down-regulating Lnc712.
Keywords: Lnc712, osteosarcoma, miR-129-5p, proliferation